Promising pharmaceutical treatment (a repurposed flu drug) for early-stage COVID-19 could be available as early as May. Testing in 340 patients in Japan appears to reduce the median duration of infection from 11 to 4 days. 91% of those treated showed improved lung condition compared to 62% without treatment. Early intervention may be key as…
Today, my goal is to bang out what *I think* may be critical botanical and nutraceutical interventions for COVID19 (SARS Cov2) prevention and treatment.
The gut is a major site for IgE-producing B cells in peanut-allergic patients, defined for the first time by new research. The authors also found evidence suggesting that isotype switching can occur in GI tissue – including switching from IgA and IgG to IgE immunoglobulin types. This new understanding presents opportunities for future interventions to…
Can we describe experiences as becoming extinct? How many of us are lacking the following: time spent in nature, and contact with biodiverse environments and microbes? Children especially, occupied by homework and screens, can miss out. Jeff Bland and Susan Prescott coauthored this new peer-reviewed paper that paints an expansive and remarkable view of the…
We are all familiar with the Wahls Protocol. But how about the story behind the protocol? Did you know, for instance, that her director at U of Iowa (Terry is a clinician-researcher) told her to write up herself as a case report? That was the first step. Her “N of 1”; then she wrote up a case series. Then she received a small grant and product for a slightly larger study. Then a million dollars. And now she’s heading into her largest study to date (yes, you will be able to refer patients). Listen to our New Frontiers conversation on how YOU as a FxMed clinician can contribute to the body of research demonstrating that: What. We. Do. Works.
Dr. Jocelyn Strand is the Director of Clinical Education at Bio-Botanical AND a great clinician herself. Prepare yourself: this is a very actionable podcast for clinicians using bioB. And for me, a huge pearl on refractory SIBO was unaddressed oral microbiome! In this episode of New Frontiers, learn how Dr. S addresses sibo using BB products. To test or not to test?
Allie was 16 years old when she first presented in my office with episodic abdominal pain in the lower right quadrant, onset 6 weeks prior, ranging from 2 to 10 on a visual analog pain scale (0=no pain, 10=worst possible pain). Her pain was not associated with reflux, fever, or blood in her stools. Allie had a prior diagnosis of eosinophilic esophagitis (EE), however treatment with diet and a proton pump inhibitor had not been successful.
This interview was, without doubt, one of the most moving for me. What Dr. Perlmutter and his son, Austin Perlmutter MD, have created is really nothing short of a revolution in returning us to our consciousness. It directly addresses one of the biggest elephants in the room – despite what we know to be good for us, good for others, good for the planet, why do we more often than not fall short of putting that knowledge into action? We. Are. Disconnected. As a people. As a world.
The newsletters I am most likely to open and read (ie actually click on to access the full text) are those from science sites that feature new research.
FDA Approves First Standardized Powder for Allergy Desensitization
Non-Stick Chemicals Found in Drinking Water Across US
Smoke-Damaged Cells Can Be Replaced – It’s Never Too Late To Quit
APOE4 Gene Carriers at Greater Risk for Memory Deficits from Soccer Headings
Antibodies Found in Rheumatoid Arthritis Linked with Chronic Obstructive Pulmonary Disorder (COPD)
Fish Oil May Improve Testicular Function
